Tizanidine Hydrochloride Capsule
Product Images NDC 50742-225

11 FDA label images from Ingenus Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 50742-225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Structure (6b60abcf 1c7f 42f4 85df 1d80fed36d54 01)

Tizanidine Structure (6b60abcf 1c7f 42f4 85df 1d80fed36d54 01)
Chemical structure of tizanidine hydrochloride, showing its molecular framework including a chlorinated aromatic ring, thiazole moiety, and imidazoline ring, labeled with HCl indicating the hydrochloride form.*
FDA Label Image

Figure 1 (6b60abcf 1c7f 42f4 85df 1d80fed36d54 02)

Figure 1 (6b60abcf 1c7f 42f4 85df 1d80fed36d54 02)
A line graph showing plasma tizanidine concentration (ng/mL) over time (hours) post-dosing. The graph compares four conditions: 2 x 4 mg tizanidine tablets with food, 2 x 4 mg tablets without food, 2 x 4 mg capsules with food, and 2 x 4 mg capsules without food. The x-axis represents hours from dosing up to 26 hours, and the y-axis shows plasma concentration levels up to 6 ng/mL, depicting the pharmacokinetic profile under these different conditions.*
FDA Label Image

Figure 2 (6b60abcf 1c7f 42f4 85df 1d80fed36d54 03)

Figure 2 (6b60abcf 1c7f 42f4 85df 1d80fed36d54 03)
Line graph showing improvement in Ashworth Score over time (hours post-dose) for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis measures improvement while the horizontal axis measures hours post-dose from 0 to 6, indicating higher improvement scores for tizanidine groups compared to placebo.*
FDA Label Image

Figure 3 (6b60abcf 1c7f 42f4 85df 1d80fed36d54 04)

Figure 3 (6b60abcf 1c7f 42f4 85df 1d80fed36d54 04)
A line graph depicting improvement in Ashworth Score over time comparing tizanidine (mean dose 28.8 mg) and placebo groups. The y-axis shows improvement scores, with lower scores indicating greater improvement. Data points with error bars are shown at End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). Tizanidine shows greater improvement compared to placebo at all time points.*
FDA Label Image

Image (6b60abcf 1c7f 42f4 85df 1d80fed36d54 143 1)

FDA Label Image

Tizanidine Hydrochloride Capsules 2 mg Bottle Label (ingenus) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 05)

Tizanidine Hydrochloride Capsules 2 mg Bottle Label (ingenus) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 05)
Tizanidine Hydrochloride Capsules 2 mg, oral dosage form, labeled strength shown on a drug label with a warning about non-interchangeability with Tizanidine tablets or Zanaflex tablets. The label states 'Rx Only' and the package contains 150 capsules. The labeler is Ingenus Pharmaceuticals, LLC, Orlando, FL.*
FDA Label Image

Tizanidine Hydrochloride Capsules 2 mg Bottle Label (stallion) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 06)

Tizanidine Hydrochloride Capsules 2 mg Bottle Label (stallion) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 06)
Label for Tizanidine Hydrochloride Capsules 2 mg by Ingenus Pharmaceuticals, LLC. The label states the capsules contain 2 mg tizanidine base, highlights that these capsules are not interchangeable with tizanidine tablets or Zanaflex tablets, and indicates a package size of 150 capsules. It includes storage instructions and manufacturing details.*
FDA Label Image

Tizanidine Hydrochloride Capsules 4 mg Bottle Label (ingenus) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 07)

Tizanidine Hydrochloride Capsules 4 mg Bottle Label (ingenus) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 07)
Label for Tizanidine Hydrochloride Capsules 4 mg by Ingenus Pharmaceuticals, LLC. The label shows a count of 150 capsules, marked as prescription only (Rx Only). It includes a warning that the capsules are not interchangeable with Tizanidine tablets or Zanaflex tablets. Storage and dosage information are provided, along with a barcode and the National Drug Code (NDC) 50742-225-15. The label also states NO VARNISH on the right side.*
FDA Label Image

Tizanidine Hydrochloride Capsules 4 mg Bottle Label (stallion) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 08)

Tizanidine Hydrochloride Capsules 4 mg Bottle Label (stallion) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 08)
Tizanidine Hydrochloride Capsules 4 mg capsule label from Ingenus Pharmaceuticals, LLC. The label includes dosage form, strength, quantity of 150 capsules, and storage instructions. It highlights that the medication is Rx only and is not interchangeable with Tizanidine tablets or Zanaflex tablets. The label also shows a barcode and the NDC 50742-225-15.*
FDA Label Image

Tizanidine Hydrochloride Capsules 6 mg Bottle Label (ingenus) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 09)

Tizanidine Hydrochloride Capsules 6 mg Bottle Label (ingenus) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 09)
Label for Tizanidine Hydrochloride Capsules 6 mg manufactured by Ingenus Pharmaceuticals, LLC. The label states it is for prescription use only (Rx Only) and the package contains 150 capsules. It includes warnings that these capsules are not interchangeable with Tizanidine tablets or Zanaflex tablets. Storage instructions and barcode are also visible.*
FDA Label Image

Tizanidine Hydrochloride Capsules 6 mg Bottle Label (stallion) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 10)

Tizanidine Hydrochloride Capsules 6 mg Bottle Label (stallion) (6b60abcf 1c7f 42f4 85df 1d80fed36d54 10)
Tizanidine Hydrochloride Capsules 6 mg by Ingenus Pharmaceuticals, LLC. The label includes an NDC number 50742-226-15 and specifies a package size of 150 capsules. It notes that each capsule contains 6.87 mg tizanidine hydrochloride USP equivalent to 6 mg tizanidine base. The label includes storage instructions, a warning to keep out of reach of children, and a caution that these capsules are not interchangeable with Tizanidine tablets or Zanaflex tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.